Edition:
India

Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

16.95EUR
19 Jul 2019
Change (% chg)

€-0.08 (-0.47%)
Prev Close
€17.03
Open
€17.05
Day's High
€17.24
Day's Low
€16.93
Volume
164,379
Avg. Vol
187,208
52-wk High
€18.00
52-wk Low
€11.40

About

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating... (more)

Overall

Beta: 0.22
Market Cap(Mil.): €2,958.70
Shares Outstanding(Mil.): 174.55
Dividend: 0.20
Yield (%): 1.20

Financials

  ALM.MC Industry Sector
P/E (TTM): 37.28 30.63 34.52
EPS (TTM): 0.45 -- --
ROI: 4.12 13.02 12.69
ROE: 6.69 14.18 17.17

BRIEF-Almirall To Pay Scrip Dividend Of 0.198 Euros Gross/Right

* SAID ON WEDNESDAY IT WOULD INCREASE SHARE CAPITAL BY ISSUING 2.3 MILLION SHARES FOR ITS SCRIP DIVIDEND PROGRAM

09 May 2019

Spanish stocks - Factors to watch on Thursday

The following Spanish stocks may be affected by newspaper reports and other factors on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

02 May 2019

BRIEF-Almirall: NICE In UK Gives Final Recommendation For Co's Drug To Treat Plaque Psoriasis

* SAID ON WEDNESDAY THAT NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) IN UK HAD PUBLISHED ITS FINAL RECOMMENDATION FOR ILUMETRI (TILDRAKIZUMAB) AS A COST-EFFECTIVE OPTION TO TREAT MODERATE-TO-SEVERE PLAQUE PSORIASIS

18 Apr 2019

Spanish stocks - Factors to watch on Friday

The following Spanish stocks may be affected by newspaper reports and other factors on Friday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

05 Apr 2019

Spanish stocks - Factors to watch on Monday

The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

01 Apr 2019

Earnings vs. Estimates